| Ytd | 54.01% | |
| 1y | 179.81% |
| Open | 15.19 | Prev Close | 15.19 | Low | 14.69 | High | 15.39 | Mkt Cap | 1.26B |
| Vol | 2.32M | Avg Vol | 5.99M | EPS | -3.38 | P/E | -4.43 | Forward P/E | -10.95 |
| Beta | 0.90 | Short Ratio | 4.70 | Inst. Own | 91.63% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 08-06 | 50-d Avg | 10.51 | 200-d Avg | 8.11 | 1yr Est | 19.33 |
REPL News
NEW YORK, Aug. 15, 2026 (GLOBE NEWSWIRE) -- Pomerantz LLP announces that a class action lawsuit has
NEW YORK, Aug. 14, 2026 (GLOBE NEWSWIRE) -- The Gross Law Firm issues the following notice to shareh
LOS ANGELES, Aug. 14, 2026 (GLOBE NEWSWIRE) -- Glancy Prongay Wolke & Rotter LLP reminds investors o
TUDRIQEV™ in combination with nivolumab receives FDA accelerated approval and will launch within 60
The law firm of [url="]Robbins Geller Rudman and Dowd LLP[/url] announces that purchasers or acquire
SAN DIEGO--(BUSINESS WIRE)---- $REPL #REPL--The case alleges Replimune and certain of its executives
NEW YORK, Aug. 13, 2026 (GLOBE NEWSWIRE) -- Kirby McInerney LLP reminds investors who purchased Repl
Replimune told investors its RP1 resubmission was a complete response to the FDA's prior deficiency
Levi and Korsinsky, LLP reminds purchasers of Replimune Group, Inc. (NASDAQ: REPL) securities of a p
NEW YORK, Aug. 13, 2026 /PRNewswire/ -- Bronstein, Gewirtz & Grossman, LLC, a nationally recognized
NEW YORK--(BUSINESS WIRE)--Levi & Korsinsky, LLP reminds purchasers of Replimune Group, Inc. (NASDAQ
NEW YORK, Aug. 13, 2026 /PRNewswire/ -- Pomerantz LLP announces that a class action lawsuit has been
Robbins LLP is Investigating Allegations that Replimune Group, Inc. Misled Investors Regarding the E
Important Information Regarding Section 20(a) Individual Liability Claims: CEO Sushil Patel and CFO
SAN DIEGO, Aug. 12, 2026 (GLOBE NEWSWIRE) -- The law firm of Robbins Geller Rudman & Dowd LLP announ
NEW YORK, Aug. 11, 2026 (GLOBE NEWSWIRE) -- Pomerantz LLP announces that a class action lawsuit has
Replimune Group, Inc. (REPL) Shareholders Who Lost Money Have Opportunity to Lead Securities Fraud L
LOS ANGELES, Aug. 11, 2026 /PRNewswire/ -- The Law Offices of Frank R. Cruz announces that investors
New York, New York--(Newsfile Corp. - August 11, 2026) - Bronstein, Gewirtz & Grossman, LLC, a natio
LOS ANGELES, Aug. 11, 2026 (GLOBE NEWSWIRE) -- Schall, Brown & Schwartz LLP (“SBS”), a national shar
Replimune Group, Inc. (NASDAQ: REPL - Get Free Report)'s stock price gapped up before the market ope
NEW YORK--(BUSINESS WIRE)---- $REPL #ClassAction--The law firm of Kirby McInerney LLP announces that
SAN DIEGO, Aug. 10, 2026 /PRNewswire/ -- Robbins Geller Rudman & Dowd LLP announces that purchasers
REPL's RP1 secures FDA approval for advanced melanoma, easing regulatory uncertainty. The company ex
SAN DIEGO, Aug. 10, 2026 /PRNewswire/ -- Shareholder rights law firm Robbins LLP informs investors t
BOSTON, Aug. 10, 2026 (GLOBE NEWSWIRE) -- Replimune Group, Inc. (Nasdaq: REPL) (“Replimune”), a comm
[url="]The DJS Law Group[/url] reminds investors of a class action lawsuit against Replimune Group,
LOS ANGELES--(BUSINESS WIRE)---- $REPL--Replimune Group, Inc. Sued for Securities Law Violations - C
Analysts upgraded Replimune, Madrigal, BBB Foods, Palantir, and Fomento Economico. See other opinion
Gainers Replimune Group (NASDAQ:REPL) stock rose 96.1% to $10.61 during Friday's regular sessio
FDA advisory panel backed Replimune's RP1 melanoma data ahead of the agency's August 2 decis
US stocks rise, Nasdaq up 300 points. Dow up 0.36%, Nasdaq up 1.31%, S&P 500 up 0.65%. Amazon sh
Gainers Replimune Group (NASDAQ:REPL) shares increased by 134.6% to $12.69 during Friday's pre-
Top Wall Street analysts upgraded IP, AXTI, REPL, and PLXS stocks with higher price targets. See wha
AMZN: 13% | Amazon.com shares are trading higher after the company reported better-than-expected Q2
Amazon reported strong Q2 results, beating revenue and earnings estimates. Shares jumped 11.9% in pr
Gainers OPKO Health (NASDAQ:OPK) shares increased by 34.7% to $1.67 during Tuesday's regular se
Gainers Gossamer Bio (NASDAQ:GOSS) shares moved upwards by 47.2% to $0.29 during Tuesday's pre-
Gainers GlucoTrack (NASDAQ:GCTK) stock moved upwards by 28.6% to $0.64 during Thursday's after-
This whale alert can help traders discover the next big trading opportunities. Whales are entities w
IDEAYA Biosciences shares (NASDAQ: IDYA) jumped 18% in pre-market trading after announcing topline
On Friday, 1043 companies hit new 52-week lows.
Stocks That Hit 52-Week Highs On Friday